Piper Jaffray has recently reduced Catheter Precision Inc (VTAK) stock to Neutral rating, as announced on August 13, 2019, according to Finviz. Analyst ratings are significant because they provide ...
Catheter Precision, Inc. (the”Company”) (NYSE American:VTAK), a US based medical device pioneering electrophysiology products, announced that it has completed a distribution agreement for LockeT with ...
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new ...